Leucadia Therapeutics
business-people-talking-in-corridor-PSVCLEM.jpg

Copy of About Us

Who We Are, What We Do 

Led by Founder and CEO Doug Ethell, Leucadia Therapeutics has looked at Alzheimer's Disease with new eyes. He has assembled an amazing team of dedicated professionals who are focused on curing Alzheimer’s Disease. 

This mission-oriented team discovered a major trigger for Alzheimer’s disease pathology and has developed a patented strategy to correct that condition.


OUR TEAM

 

Learn More

Leucadia Therapeutics has a novel approach to defeat AD

Get in touch with us ▸

Doug.png

Doug Ethell, PhD

FOUNDER & CEO

Previously Professor of Neuroscience Chair, Graduate College of Biomedical Science Head, Molecular Neurobiology Group, 15 years of Alzheimer’s Disease research, Awarded >$3M in research funding. Authored >85 papers & abstracts

 
 
Dave.png
 

David Gobel 

SENIOR ADVISOR

Serial Entrepreneur
Incubator Specialist, CEO of Methuselah Foundation, Former Chief Venture Strategist at TSA                     

 

 

 
Randy.png

Randy Woltjer, MD, PhD

SCIENTIFIC ADVISORY BOARD

Neuropathologist Layton Aging & Alzheimer’s Disease Center Oregon Health Sciences University, Portland, OR                          

 

 
 

Javed Siddiqui, MD, PhD

SCIENTIFIC ADVISORY BOARD

Neurosurgeon Arrowhead Regional Medical Center
Director, Desert Regional Medical Center Neurological Surgery Residency Desert Regional Medical Center, Palm Springs, CA

 
 

Dan Miulli, D.O. MS, FACOS

SCIENTIFIC ADVISORY BOARD

Neurosurgeon, Arrowhead Regional Medical Center

Director, Neurosurgery Residence Program

 

Founding Investors